BIOPROM opens in Gelendzhik Medical technology on show

Oct 5

Alena Evtyakova reports from the third BIOPROM forum's opening in Gelendzhik. Exhibitors describe biodegradable magnesium surgical implants, Rostec's individualized skin bioprinting robot still undergoing clinical evaluation, and a domestic dialysis machine with monitoring features and proposed production and deliveries. Sechenov University and Sirius representatives discuss specialist training and a development-to-validation cycle. A pharmaceutical executive argues Russia can manufacture complex medicines domestically. Denis Manturov discusses the approved bioeconomy strategy through 2036 and reports three-percent output growth over nine months; Mikhail Kovalchuk explains everyday microbial production and emphasizes biosecurity. The report gives the exhibition and business programme's scale and says the forum continues tomorrow. Testing, forecasts and independence claims retain attribution and qualifications.

At BIOPROM, Shmeleva presents Sirius's university, laboratories, education and innovation infrastructure as a bridge from scientific ideas through controlled trials and scaling to industry. She cites 113 resident companies, a pharmaceutical pilot being created with R-Pharm and early agricultural-cluster work. She emphasizes responsible chief designers and real industry tasks. Vremya's shorter excerpt describes the same education-to-implementation-and-regulation cycle. Planned facilities are distinguished from operating infrastructure.